DK0604551T3 - Ny cellelinje, som støtter replikation af baculovirus - Google Patents

Ny cellelinje, som støtter replikation af baculovirus

Info

Publication number
DK0604551T3
DK0604551T3 DK92920411T DK92920411T DK0604551T3 DK 0604551 T3 DK0604551 T3 DK 0604551T3 DK 92920411 T DK92920411 T DK 92920411T DK 92920411 T DK92920411 T DK 92920411T DK 0604551 T3 DK0604551 T3 DK 0604551T3
Authority
DK
Denmark
Prior art keywords
cell line
new cell
line supporting
baculovirus replication
baculovirus
Prior art date
Application number
DK92920411T
Other languages
Danish (da)
English (en)
Inventor
Robert R Granados
Original Assignee
Thompson Boyce Plant Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thompson Boyce Plant Res filed Critical Thompson Boyce Plant Res
Application granted granted Critical
Publication of DK0604551T3 publication Critical patent/DK0604551T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0601Invertebrate cells or tissues, e.g. insect cells; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/60Buffer, e.g. pH regulation, osmotic pressure
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/70Undefined extracts
    • C12N2500/74Undefined extracts from fungi, e.g. yeasts
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/14011Baculoviridae
    • C12N2710/14111Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK92920411T 1991-09-16 1992-09-09 Ny cellelinje, som støtter replikation af baculovirus DK0604551T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US76069791A 1991-09-16 1991-09-16
US07/839,918 US5298418A (en) 1991-09-16 1992-02-21 Cell line isolated from larval midgut tissue of Trichoplusia ni
PCT/US1992/007616 WO1993006210A1 (fr) 1991-09-16 1992-09-09 Nouvelles lignees cellulaires utilisables pour la replication de baculovirus

Publications (1)

Publication Number Publication Date
DK0604551T3 true DK0604551T3 (da) 2002-02-25

Family

ID=27116857

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92920411T DK0604551T3 (da) 1991-09-16 1992-09-09 Ny cellelinje, som støtter replikation af baculovirus

Country Status (6)

Country Link
US (2) US5298418A (fr)
EP (1) EP0604551B1 (fr)
CA (1) CA2116110C (fr)
DE (1) DE69232171T2 (fr)
DK (1) DK0604551T3 (fr)
WO (1) WO1993006210A1 (fr)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9323495D0 (en) * 1993-11-15 1994-01-05 Zeneca Ltd Biological control agent
US6403375B1 (en) * 1994-08-24 2002-06-11 Boyce Thompson Institute For Plant Research, Inc. Establishment of Trichoplusia ni cell lines in serum-free medium for recombinant protein and baculovirus production
US5925346A (en) * 1995-06-01 1999-07-20 Queen's University At Kingston Antisense strategy for the production of species specific viral insecticides
ES2321991T3 (es) * 1996-12-09 2009-06-15 Merck Patent Gmbh Receptor de adhesion alfavbet3 recombinante soluble.
US5686305A (en) * 1997-02-26 1997-11-11 Boyce Thompson Institute For Plant Research, Inc. Establishment of new cell lines from Pseudaletia unipuncta with differential responses to baculovirus
AU772172B2 (en) 1998-09-23 2004-04-08 Zymogenetics Inc. Cytokine receptor zalpha11
US6103526A (en) * 1998-10-08 2000-08-15 Protein Sciences Corporation Spodoptera frugiperda single cell suspension cell line in serum-free media, methods of producing and using
CA2354325C (fr) 1998-12-07 2011-08-16 Zymogenetics, Inc. Zvegf3 homologue du facteur de croissance
DK1165791T3 (da) 1999-03-09 2008-02-11 Zymogenetics Inc Humant cytokin som zalpha-receptor-ligand og anvendelse deraf
DE60045931D1 (de) 1999-07-07 2011-06-16 Zymogenetics Inc Menschliches Rezeptor für Zytokine
DE60042410D1 (de) * 1999-08-05 2009-07-30 Merck & Co Inc Bestimmung humanes Cytochrom P450 3A4 (CYP3A4)
JP2003524415A (ja) 1999-12-23 2003-08-19 ザイモジェネティクス,インコーポレイティド サイトカインzcyto18
DE60125543T2 (de) 2000-04-05 2007-10-04 Zymogenetics, Inc., Seattle Löslicher zytokinrezeptor zalpha11
WO2001087933A2 (fr) 2000-05-11 2001-11-22 Zymogenetics, Inc. Peptides de type zsig33
WO2002000721A2 (fr) 2000-06-26 2002-01-03 Zymogenetics, Inc. Zcytor17, recepteur de la cytokine
ATE360696T1 (de) 2000-06-30 2007-05-15 Zymogenetics Inc Interferon-ähnliches protein zcyto21
CA2438682A1 (fr) 2001-02-20 2002-08-29 Zymogenetics, Inc. Anticorps liant a la fois bcma et taci
EA010594B1 (ru) 2001-05-24 2008-10-30 Займодженетикс, Инк. Слитые белки taci-иммуноглобулина
MXPA04004167A (es) 2001-11-05 2004-07-08 Zymogenetics Inc Antagonistas de interleucina-21.
ES2377188T3 (es) 2002-01-18 2012-03-23 Zymogenetics, Inc. Nuevo ligando de citocina ZCYTOR17
ES2382800T3 (es) 2002-01-18 2012-06-13 Zymogenetics, Inc. Multímeros Zcytor17 receptores de citocinas
EP1497415B1 (fr) 2002-04-19 2010-12-29 ZymoGenetics, L.L.C. Methodes d'identification ou modulation de l'interaction d'un recepteur de cytokine et son ligand
US7179648B2 (en) * 2002-11-15 2007-02-20 Boyce Thompson Institute For Plant Research, Inc. Clonal cell lines derived from BTI-TN-5B1-4
PT2251353E (pt) 2003-08-07 2013-05-07 Zymogenetics Inc Preparações homogéneas de il-28 e il-29
KR20060126449A (ko) * 2003-09-23 2006-12-07 파브릴, 인크. 자가 유도된 항원을 특이적-결합 세포감소제와 병용하여 b세포 병증을 개선시키는 방법
ATE517914T1 (de) 2004-03-08 2011-08-15 Zymogenetics Inc Dimere fusionsproteine und materialien und verfahren zu deren herstellung
WO2006012644A2 (fr) 2004-07-29 2006-02-02 Zymogenetics, Inc. Utilisation des molecules il-28 et il-29 pour traiter le cancer et les troubles autoimmuns
EP1781784A2 (fr) 2004-08-02 2007-05-09 BASF Plant Science GmbH Procede pour l'isolement de sequences de terminaison de transcription
EP2192132A3 (fr) 2005-02-08 2010-08-18 ZymoGenetics, Inc. Anticorps et partenaires de liaison anti-il-20, anti-il-22 et anti-il-22ra, et methodes d'utilisation de ces anticorps et partenaires de liaison dans des processus inflammatoires
JP2008544746A (ja) 2005-05-12 2008-12-11 ザイモジェネティクス, インコーポレイテッド 免疫応答を調節するための組成物および方法
US7879012B2 (en) * 2006-04-11 2011-02-01 Nypro Inc. Medical valve with resilient sealing member
US7776589B1 (en) * 2006-08-31 2010-08-17 Schering Corporation Polynucleotides encoding polypeptide fragments of protein kinase B gamma (AKT3)
EP2602263B1 (fr) 2007-11-21 2019-07-17 Roskilde Universitet Polypeptides comprenant une activité de liaison à la glace
EP2231702A1 (fr) * 2007-12-21 2010-09-29 Ifxa A/s Inhibiteur de protéases
MX2010008083A (es) 2008-01-25 2010-12-20 Univ Aarhus Inhibicion de exositios selectivos de actividad papp-a contra igfbp-4.
ES2456296T3 (es) 2008-03-27 2014-04-21 Zymogenetics, Inc. Composiciones y procedimientos para inhibir PDGFR beta y VEGF-A
US8658766B2 (en) 2008-06-27 2014-02-25 Zymogenetics, Inc. Soluble hybrid Fcγ receptors and related methods
US8822642B2 (en) 2010-06-09 2014-09-02 Zymogenetics, Inc. Dimeric fusion proteins and related compositions and methods
HK1200842A1 (en) 2011-11-18 2015-08-14 Albumedix Ltd Proteins with improved half-life and other properties
CN103352024B (zh) * 2012-11-19 2015-07-15 青岛农业大学 一种昆虫中肠细胞离体培养方法
EP2992329A1 (fr) 2013-05-03 2016-03-09 Eleven Biotherapeutics, Inc. Variantes d'albumine se liant à fcrn
WO2014202089A2 (fr) 2013-06-18 2014-12-24 Roskilde Universitet Variants de polypeptides antigel
CN104087549B (zh) * 2014-06-11 2016-06-29 广东华南联合疫苗开发院有限公司 高产杆状病毒的昆虫细胞系及其应用
WO2016154338A1 (fr) * 2015-03-23 2016-09-29 Boyce Thompson Institute For Plant Research Inc. Lignées cellulaires exemptes d'infection virale et leurs procédés de production
DK3328881T3 (da) 2015-09-08 2019-10-07 Theripion Inc Apoa-1 fusionspolypeptider og relaterede sammensætninger og fremgangsmåder
KR102784293B1 (ko) 2015-09-21 2025-03-20 압테보 리서치 앤드 디벨롭먼트 엘엘씨 Cd3 결합 폴리펩타이드
WO2018136163A2 (fr) 2016-12-09 2018-07-26 Theripion, Inc. Polypeptides de fusion apoa-1 en tandem
IL272103B2 (en) 2017-07-20 2024-10-01 Aptevo Res & Development Llc Antigen binding proteins binding to 5T4 and 4-1BB and related compositions and methods of treating cancer
AU2018391831B2 (en) 2017-12-20 2022-08-04 Harbour Biomed (Shanghai) Co., Ltd Antibodies binding CTLA-4 and uses thereof
US10150801B1 (en) 2017-12-27 2018-12-11 Imunami Laboratories Pte. Ltd. Recombinant polypeptides and methods of use thereof
WO2019132765A1 (fr) 2017-12-27 2019-07-04 Imunami Laboratories Pte. Ltd. Polypeptides recombinants et leurs procédés d'utilisation
CN108531442B (zh) * 2018-04-28 2021-10-01 青岛农业大学 一种无血清悬浮培养的昆虫细胞系及其应用
EP4021512A1 (fr) 2019-08-26 2022-07-06 Imunami Laboratories Pte. Ltd. Polypeptides recombinants et leurs méthodes d'utilisation
US10675332B1 (en) 2019-08-26 2020-06-09 Imunami Laboratories Pte. Ltd. Recombinant polypeptides and methods of use thereof
EP4168034B1 (fr) 2020-06-22 2025-11-26 Imunami Laboratories Pte. Ltd. Alpha-a-crystallin recombinante et combinaisons pour utilisation dans le traitement du cancer
AU2022224584A1 (en) 2021-02-19 2023-09-21 Theripion, Inc. Paraoxonase fusion polypeptides and related compositions and methods
CN120584137A (zh) 2023-01-06 2025-09-02 阿帕特夫研究和发展有限公司 双特异性pd-l1和cd40结合分子以及其用途
WO2024259220A1 (fr) 2023-06-15 2024-12-19 Theripion, Inc. Polypeptides de fusion de pon3 et de pon1 évoluée

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5024947A (en) * 1987-07-24 1991-06-18 Cetus Corporation Serum free media for the growth on insect cells and expression of products thereby

Also Published As

Publication number Publication date
EP0604551A1 (fr) 1994-07-06
CA2116110A1 (fr) 1993-04-01
US5300435A (en) 1994-04-05
DE69232171T2 (de) 2002-07-18
WO1993006210A1 (fr) 1993-04-01
DE69232171D1 (de) 2001-12-06
US5298418A (en) 1994-03-29
EP0604551B1 (fr) 2001-10-31
CA2116110C (fr) 1997-11-04

Similar Documents

Publication Publication Date Title
FI931367L (fi) Tvaettmedelskompositioner, som innehaoller polyhydroxifettsyraamider ochen skumfoerstaerkare
FI922222A7 (fi) Kopplingsanordning, som foermaor laosa spinalosteosyntesfaestanordningar
FI925615L (fi) Stabiliserade farmaceutiska kompositioner, som innehaoller en HMG-CoA-reduktas-inhibitorfoerening
FI910256L (fi) Foerfarande foer bestaemning av mikrobpatogener, som sprids med vatten, och fekala foeroreningar indikerande aemnen i vattenprov och testfoerpackning.
FI913215L (fi) Additionspolymeriseringskatalysator, som aktiveras medelst oxidering.
FI925802L (fi) Hyaluronsyraderivat, som aer oloesliga i vatten
FI924790L (fi) 2-deoxi-2,3-didehydro-n-acetylneuraminsyrans derivat och analoger och deras anvaendning som antivirala aemnen
FI914619A7 (fi) Hydroxylfunktionaliserade polyeteraminer som barriaerfoerpackning foer syrekaensliga materialer.
FI914796L (fi) Omaettade hydroxialkylkinolinsyror som leukotrienantagonister.
FI914596L (fi) Biaxialt orienterad polypropylenfolie avsedd som foerpackningsomslag.
FI914336L (fi) Alginattyg med foerbaettrad absorptions- foermaoga, anvaendning av detta som saor- och braennskadefoerband och foerfarande foer framstaellning av detta.
FI923281L (fi) Foerbaettrade desinfektionsloesningar, som innehaoller vaeteperoxid
FI910993A7 (fi) Hjaelpmedel som foerbaettrar glidegenskaper.
FI912834A0 (fi) Polyvinylalkoholharts, som aer loesligt i vattenhaltiga pappersbestrykningskompositioner med hoeg torrsubstanshalt utan yttre uppvaermning.
FI915357L (fi) Optisk bakskiva som foerbinder kretskort.
FI914004A0 (fi) Epoxifunktionella siloxanhartskopolymerer som loesgoeringsreglerande tillaeggsaemnen.
FI914797L (fi) Maettade hydroxialkylkinolinsyror som leukotrienantagonister.
FI922235L (fi) Foerfarande foer framstaellning av 3-aminopyridazinderivat, som verkar paodet centrala nervsystemet
FI915626L (fi) Magnesiumkloridpartiklar med polyederstruktur, katalytisk komposant med dessa partiklar som baerare och olefiner, som faotts med hjaelp av denna katalytiska komposant.
FI911512L (fi) Oeverbasiska calixarater, foerfarande foer deras framstaellning, kompositioner innehaollande desamma och deras anvaendning som tillsatsaemnen i smoerjaemnen.
FI912468L (fi) Oxidantkaensliga och -okaensliga aromatiska estrar som inhibitorer foer humant neutrofilelastas.
FI910572A7 (fi) Regnmaetare med anordning som paovisar tilltaeppning.
FI913201A7 (fi) Ymppolysackarider, deras framställningsförfarande och deras användning som sekvesteringsagenter
FI915568L (fi) Polyamidhartskompositioner foer anvaendning som bindemedel foer laminerande tryckfaergshartser.
FI920735A7 (fi) Vattenhaltiga polymerdispersioner som innehaoller organiska foereningar med karbonat- och karbonylgrupper, liksom daermed framstaellda maolnings-och ytbehandlingssystem